Sponsored Links
| New Phase 3 Study Results Show REMICADE(R) Is Effective In The Treatment Of Pediatric Patients With Moderate To Severe Ulcerative Colitis |
 |
 |
 |
| Medical News - Crohn's | |||
|
Data from a Phase 3 randomized, multicenter, open-label study demonstrated clinical response with REMICADE® (infliximab) in the treatment of pediatric patients with moderately to severely active ulcerative colitis (UC), and showed a safety profile consistent with previous clinical trials conducted in an adult population... Read more: Crohn's / IBD News From Medical News Today
|